About Veeprho Pharma
Veeprho Pharma was a Natural Resources company based in Pune (India) founded in 2010. It provides assaying, melting, and refining services for gold and silver in Africa. It operates on a B2B model in Natural Resources and Industrial Goods & Manufacturing sectors. The company has 28 employees. Its Indian entity Veeprho Laboratories Private Limited reported revenue of ₹5.81 Cr. The company is recorded as dissolved. Veeprho Pharma offers products and services including Assaying, Melting, and Refining. Its focus areas include Resources and Energy, Mining Tech, Precious Metals and Assaying Services. Its competitors include Sai Life Sciences and NFIL; 1 of its 2 listed competitors has raised funding.
Company details
Aldango LTD, established in 2017 in Kigali, Rwanda, specializes in gold and silver processing. They use advanced methods like the Fire Assay for assaying and an electric induction furnace for melting. The company provides high-quality refining services to the mining industry across Africa, ensuring environmentally friendly practices and compliance with international standards. Their facilities are located in the Special Economic Zone, serving clients in the metals sector.
- Headquarters Pune, India
- Employees 28
- SectorsNatural ResourcesIndustrial Goods & Manufacturing
- Email••••••••
- Website veeprhopharma.com
- Social X
- Legal Name Veeprho Laboratories Private Limited
- Date of Incorporation 05 Jul, 2011
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹5.81 Cr
FY 2025 · -41% YoY
- Net Profit₹22.6 Lakh
FY 2025 · 4% margin
- EBITDA₹58.8 Lakh
FY 2025 · 10% margin
- Employee Count28
Associated legal entities of Veeprho Pharma
Veeprho Pharma operates through Veeprho Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Veeprho Laboratories Private Limited CIN U24230MH2011PTC387752 | Active | 05 Jul 2011 | Navi Mumbai, Maharashtra | ₹5.8 Cr | 28 | 4 | View details |
Products & Services of Veeprho Pharma
Veeprho Pharma offers a comprehensive portfolio of products and services, including Assaying, Melting, and Refining.
Determines gold and silver concentration using Fire Assay Method.
Melts gold and silver via induction furnace for various forms.
Chemically purifies scrap gold and silver to high standards.
Board of directors of Veeprho Laboratories Private Limited (Veeprho Pharma)
Veeprho Laboratories Private Limited is the primary company behind Veeprho Pharma. The board of Veeprho Laboratories Private Limited currently have 4 directors; the longest-serving is Venkat Dagduji Shinde, appointed in 2011. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkat Dagduji Shinde DIN 03090230 | Director | 05 Jul 2011 | 15 yrs 3 mo | Veeprho Laboratories Private Limited |
| Rohit Arun Tembhurnikar DIN 08702866 | Director | 18 Feb 2020 | 6 yrs 8 mo | Veeprho Laboratories Private Limited |
| Sandip Namdeo Lakudzode DIN 08702867 | Director | 18 Feb 2020 | 6 yrs 8 mo | Veeprho Laboratories Private Limited |
| Pravina Venkat Shinde DIN 02907630 | Director | 15 Oct 2025 | 1 yr | Veeprho Laboratories Private Limited |
Financials of Veeprho Pharma
Figures of Veeprho Laboratories Private Limited, the primary company behind Veeprho Pharma, for FY 2025. Revenue was ₹5.81 Cr (-41% year on year). Net profit was ₹22.6 Lakh (4% margin). EBITDA was ₹58.8 Lakh (10% margin). Revenue has grown at a compounded annual rate of -18% over three years and -6% over five years.
- ₹5.81 CrRevenue · FY 2025 · -41% YoY
- ₹22.6 LakhNet profit · 4% margin
- ₹58.8 LakhEBITDA · 10% margin
- ₹25 LakhPaid-up capital
- 28Employees (provident fund records)
- -18%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Veeprho Laboratories Private Limited are on its company page.
Detailed financial statements for Veeprho Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Veeprho Pharma
Veeprho Pharma has 2 listed competitors in our database, 1 of them funded. They include Sai Life Sciences and NFIL.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| nfil.in | 1967 | Mumbai, India | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. |
Detailed competitors of Veeprho Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Services for Mining Industry
3 companies that operate in the same segment as Veeprho Pharma (Services for Mining Industry) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Bulk material handling and mineral processing systems are manufactured. | 1947 | Chennai, Tamil Nadu, India | USD 67.25 M | 2,310 | ||
Development and exploration company focused on producing coal | 2006 | Gurugram, Haryana, India | USD 25.9 M | 574 | ||
Contract-based coal mining services are offered by SMASL. | 1989 | Gurugram, Haryana, India | USD 40.7 M | USD 119.62 M | 774 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Veeprho Pharma
Veeprho Pharma was founded in 2010.
Veeprho Pharma is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Veeprho Pharma has 28 employees.
The primary company behind Veeprho Pharma, Veeprho Laboratories Private Limited, reported revenue of ₹5.81 Cr for FY 2025, down 41% year on year.
Aldango LTD, established in 2017 in Kigali, Rwanda, specializes in gold and silver processing. They use advanced methods like the Fire Assay for assaying and an electric induction furnace for melting. The company provides high-quality refining services to the mining industry across Africa, ensuring environmentally friendly practices and compliance with international standards. Their facilities are located in the Special Economic Zone, serving clients in the metals sector.
Veeprho Pharma's top competitors include Sai Life Sciences and NFIL.
Veeprho Pharma offers Assaying, Melting, and Refining.
Veeprho Pharma operates through Veeprho Laboratories Private Limited.
The legal entities of Veeprho Pharma currently have 4 directors, including Rohit Arun Tembhurnikar, Sandip Namdeo Lakudzode, Pravina Venkat Shinde and others.